Initial Order for 5,000 TASER X26 Units
SCOTTSDALE, Ariz., Jan. 5, 2009 (GLOBE NEWSWIRE) -- TASER(r) International,
Inc. (Nasdaq:TASR), the market leader in advanced electronic control devices,
today announced that it received an initial order from the United Kingdom for
5,000 TASER(r) X26(tm) Electronic Control Devices (ECDs) and TASER related
accessories following the announcement last month by the United Kingdom Home
Secretary to provide 10,000 TASER devices for front line law enforcement
officers throughout England and Wales.
"The United Kingdom's expansion of its TASER program comes after years of
careful consideration and pilot programs proving the positive effects and
life-saving capabilities of the TASER technology," said Tom Smith, Chairman of
TASER International. "United Kingdom law enforcement agencies have led the way
throughout Europe in terms of extensive testing, training and use of TASER
technology. This order will further improve public and officer safety
throughout the United Kingdom," concluded Smith.
TASER ECDs are currently deployed by more than 13,500 law enforcement agencies
in the United States, Canada, United Kingdom, France, Korea and more than 40
other countries worldwide.
The order shipped in the fourth quarter of 2008, driving total shipped revenue
for the quarter estimated to approximately $25 million.
About TASER International, Inc.
TASER International's products protect life. TASER provides advanced Electronic
Control Devices (ECDs) for use in the law enforcement, medical, military,
corrections, professional security, and personal protection markets. TASER
devices use proprietary technology to incapacitate dangerous, combative, or
high-risk subjects who pose a risk to law enforcement officers, innocent
citizens, or themselves in a manner that is generally recognized as a safer
alternative to other uses of force. For more information, please call TASER
International at (800) 978-2737 or visit our website at www.TASER.com.
The TASER International logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=2931
Note to Investors
This press release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended (the "Securities Act"),
and Section 21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), including statements, without limitation, regarding our
expectations, beliefs, intentions or strategies regarding the future. We intend
that such forward-looking statements be subject to the safe-harbor provided by
the Private Securities Litigation Reform Act of 1995. The forward-looking
information is based upon current information and expectations regarding TASER
International. These estimates and statements speak only as of the date on
which they are made, are not guarantees of future performance, and involve
certain risks, uncertainties and assumptions that are difficult to predict.
Therefore, actual outcomes and results could materially differ from what is
expressed, implied, or forecasted in such forward-looking statements.
TASER International assumes no obligation to update the information contained
in this press release. These statements are qualified by important factors that
could cause our actual results to differ materially from those reflected by the
forward-looking statements. Such factors include but are not limited to: (1)
market acceptance of our products; (2) our ability to establish and expand
direct and indirect distribution channels; (3) our ability to attract and
retain the endorsement of key opinion-leaders in the law enforcement community;
(4) the level of product technology and price competition for our products; (5)
the degree and rate of growth of the markets in which we compete and the
accompanying demand for our products; (6) risks associated with rapid
technological change and new product introductions; (7) competition; (8)
litigation including lawsuits resulting from alleged product related injuries
and death; (9) media publicity concerning allegations of deaths and injuries
occurring after use of the TASER device and the negative effect this publicity
could have on our sales; (10) TASER device tests and reports; (11) product
quality; (12) implementation of manufacturing automation; (13) potential
fluctuations in our quarterly operating results; (14) financial and budgetary
constraints of prospects and customers; (15) order delays; (16) dependence upon
sole and limited source suppliers; (17) negative reports concerning the TASER
device; (18) fluctuations in component pricing; (19) government regulations and
inquiries; (20) dependence upon key employees and our ability to retain
employees; (21) execution and implementation risks of new technology; (22)
ramping manufacturing production to meet demand; (23) medical and safety
studies; (24) field test results; and (25) other factors detailed in our
filings with the Securities and Exchange Commission, including, without
limitation, those factors detailed in the Company's Annual Report on Form 10-K
and its Form 10-Qs.
The statements made herein are independent statements of TASER International.
The inclusion of any third parties does not represent an endorsement of any
TASER International products or services by any such third parties.
CONTACT: TASER International, Inc.
Steve Tuttle, Vice President of Communications
Media ONLY Hotline: (480) 444-4000
United Kingdom Expands TASER Program to Patrol Officers
| Source: TASER International, Inc.